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a  b  s  t  r  a  c  t
Mitochondrial  biogenesis  and  metabolism  have  recently  emerged  as  important  actors  of stemness  and
differentiation.  On  the  one  hand,  the  differentiation  of  stem  cells  is associated  with  an  induction  of
mitochondrial  biogenesis  and  a shift  from  glycolysis  toward  oxidative  phosphorylations  (OXPHOS).  In
addition,  interfering  with  mitochondrial  biogenesis  or function  impacts  stem  cell  differentiation.  On the
other  hand,  some  inverse  changes  in  mitochondrial  abundance  and function  are  observed  during  the
reprogramming  of  somatic  cells  into  induced  pluripotent  stem  cells  (iPSCs).  Yet although  great  promises
in  cell  therapy  might  generate  better knowledge  of  the mechanisms  regulating  the stemness  and  differ-
entiation  of somatic  stem  cells  (SSCs)—which  are  preferred  over  embryonic  stem  cells  (ESCs)  and  iPSCs
because  of ethical  and  safety  considerations—little  interest  was  given  to  the study  of their  mitochondria.
This  study  provides  a  detailed  characterization  of the mitochondrial  biogenesis  occurring  during  the  hep-
atogenic  differentiation  of  bone  marrow-mesenchymal  stem  cells  (BM-MSCs).  During  the  hepatogenic
differentiation  of  BM-MSCs,  an  increased  abundance  of  mitochondrial  DNA  (mtDNA)  is  observed,  as  well
as an  increased  expression  of several  mitochondrial  proteins  and  biogenesis  regulators,  concomitant
with  increased  OXPHOS  activity,  capacity,  and  efficiency.  In addition,  opposite  changes  in mitochondrial
morphology  and in  the  abundance  of  several  OXPHOS  subunits  were  found  during  the spontaneous  ded-
ifferentiation  of  primary  hepatocytes.  These  data  support  reverse  mitochondrial  changes  in a  different
context  from  genetically-engineered  reprogramming.  They  argue in  favor  of a  mitochondrial  involvement
in  hepatic  differentiation  and  dedifferentiation.
©  2014  Elsevier  Ltd.  All  rights  reserved.Abbreviations: 1AT, -1-antitrypsin; BM-MSCs, bone-marrow mesenchymal stem cel
xidase; COX4, subunit IV of the cytochrome c oxidase; DRP1, dynamin-related protein 1; E
nic  stem cells; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; G6PC, gluc
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DNA, nuclear DNA; OXPHOS, oxidative phosphorylation; PEPCK1, phosphoenolpyruvate 
ctivated receptor; PPIE, peptidyl-prolyl cis-trans isomerase E; PRC, PGC-1-related coacti
,3-dioxygenase; TFs, transcription factors; TFAM, mitochondrial transcription factor A.
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. Introduction
Depending on physiologic and cellular cues, mitochondria can
isplay differences in their abundance, morphology and func-
ions. Mitochondrial biogenesis is a complex process involving
ipid membrane formation, mitochondrial DNA (mtDNA) replica-
ion and transcription, and coordinated synthesis of mitochondrial
roteins encoded by both nuclear and mitochondrial genomes. The
oordination between the nuclear and mitochondrial genomes is
chieved through the expression of nucleus-encoded mitochon-
rial proteins which control mtDNA replication and transcription,
uch as the mitochondrial transcription factor A (TFAM). In the
ucleus, the expression of mitochondrial genes is controlled by
 limited number of transcription factors (TFs), including NRF-1
nd -2 (nuclear respiratory factors 1 and 2), PPARs (peroxisome
roliferator-activated receptors , /, and ) and ERRs (estrogen-
elated receptors , , and ). (Interested readers can refer to (Hock
nd Kralli, 2009) for a detailed review of the involvement of these
Fs in mitochondrial biogenesis). The activity of these TFs is itself
ontrolled by the PGC-1 (PPAR gamma  coactivator 1) family of
oactivators: PGC-1;  PGC-1;  and PRC (PGC-1-related coactiva-
or) (Hock and Kralli, 2009). Among these, the best described is
GC-1, a protein considered to be the master regulator of mito-
hondrial biogenesis and function (Fernandez-Marcos and Auwerx,
011).
A number of recent studies evidenced an enhanced mitochon-
rial biogenesis in various stem cell differentiation models (Chen
t al., 2012, Xu et al., 2013). In ESCs, the mitochondrial phenotype
as been described as “immature,” consisting of few mitochondria,
ontaining poorly developed cristae, and displaying a perinuclear
ocation (Cho et al., 2006, Lonergan et al., 2007, St John et al., 2005).
hile these cells mainly rely on glycolysis for their energy pro-
uction, differentiating cells display an increased mitochondrial
ass and mtDNA abundance, a more developed mitochondrial net-
ork, and a shift toward OXPHOS to meet their energy demands
Chung et al., 2010, Facucho-Oliveira et al., 2007, Lonergan, Bavister,
007, Prigione et al., 2010, Suhr et al., 2010). In addition, the use
f molecules promoting or inhibiting mitochondrial biogenesis or
unction, or interfering with the expression of mitochondrial bio-
enesis regulators or proteins involved in mitochondrial function,
as been demonstrated to impact stemness and cell differenti-
tion (Huang et al., 2011, Tormos et al., 2011, Xu et al., 2013).
or instance, the attenuation of mitochondrial function using car-
onyl cyanide m-chlorophenylhydrazone (CCCP) in ESCs results
n increased transcriptional levels of the pluripotency markers
ox2, Oct4, and Nanog, and in the repression of transcriptional
rograms associated with lineage differentiation (Mandal et al.,
011). Conversely, the reprogramming of somatic cells into iPSCs
s accompanied by inverse modifications, in a process called “mito-
hondrial rejuvenation” (Folmes et al., 2011, Prigione, Fauler, 2010,
uhr, Chang, 2010, Varum et al., 2011). These data have led to the
ypothesis that transitions in mitochondrial metabolism regulate,
r are regulated by, differentiation and reprogramming events.
In order to better appreciate the involvement of mitochondria in
ifferentiation processes, two main points remain to be addressed.
n the one hand, due to the lack of an extensive characterization
f the mitochondria in the different stem cell differentiation mod-
ls previously studied, it is currently unclear if the mitochondrial
iogenesis process always involves an increase in all or some of
he constituents of mitochondria (membrane, protein and mtDNA)
nd if it systematically results in increased mitochondrial activ-
ty. In addition, the kinetics of the mitochondrial biogenesis has
ot been addressed in most studies, and it remains unclear when,
nd for how long, the mitochondrial biogenesis is induced. On
he other hand, while most studies of mitochondrial biogenesis
n stemness and differentiation have been performed on ESCs andemistry & Cell Biology 54 (2014) 174–185 175
iPSCs, few studies report an enhanced mitochondrial biogenesis
during the differentiation of SSCs such as mesenchymal stem cells
(MSCs) (Chen et al., 2008, Palomaki et al., 2013, Pietila et al., 2012,
Tormos, Anso, 2011). If the mitochondrial biogenesis represents a
hallmark of all types of stem cell differentiation processes therefore
remains to be demonstrated. Although not as pluripotent as ESCs,
SSCs offer several advantages over ESCs/iPSCs in cell therapy, such
as better safety and fewer ethical concerns. Among SSCs, MSCs can
differentiate into multiple cell types, including hepatocytes (Banas
et al., 2007, Mosna et al., 2010). Interestingly, hepatocytes display a
much higher expression of several mitochondrial OXPHOS subunits
(Suppl. Fig. 1) than BM-MSCs, suggesting that a strong mitochon-
drial biogenesis might be associated with their differentiation.
Primary hepatocytes, however, cannot be maintained in culture
in a fully differentiated and highly metabolic state. Hepatocytes are
subject to a rapid dedifferentiation process during in vitro culture.
This process is initiated during their isolation, and is characterized
by: rapid loss of hepatic gene expression, polarity, and activity;
re-entry into the cell cycle; and upregulation of cytoskeleton and
mesenchymal proteins such as vimentin (Elaut et al., 2006, Meyer
et al., 2013). Improving our understanding of the mechanisms
involved in hepatocyte dedifferentiation, and eventually counter-
acting them, could thus lead to many important applications such as
pharmacological testing. The demonstration of an involvement of
mitochondria in hepatic differentiation and dedifferentiation pro-
cesses might therefore be used as a starting point for studies aimed
to improve/limit hepatocyte differentiation/dedifferentiation.
In this study, we provide a kinetic and detailed characterization
of the mitochondrial biogenesis initiated during the hepatogenic
differentiation of BM-MSCs. We  provide evidence for inverse mito-
chondrial changes during the spontaneous dedifferentiation of
hepatocytes. We  initially found evidence for an induction of mito-
chondrial and mtDNA abundance and an increased expression of
several mitochondrial proteins and mitochondrial biogenesis reg-
ulators, concomitant with an increased oxidative activity, during
the early hepatogenic differentiation of BM-MSCs. In contrast, dur-
ing primary hepatocyte dedifferentiation we  found a reduction
of several mitochondrial proteins involved in OXPHOS. Further-
more, while a fission of the mitochondrial network was  observed
in the differentiation model, a trend toward an increased fusion
was observed during hepatocyte dedifferentiation. These data
demonstrate the existence of opposite changes in mitochondrial
morphology and function between the hepatic differentiation and
hepatocyte dedifferentiation models. They further support the
involvement of mitochondria in stemness and cell differentiation.
2. Material and methods
2.1. Ethical guidelines
This study was approved by the local ethics committee of the
Jules Bordet Institute (Belgium) for obtaining human BM-MSCs
after informed consent from donors. The use of human liver tissue
for research was  approved by the ethical committee of St-Luc Hos-
pital and of the Université Catholique de Louvain, Belgium. Primary
hepatocytes were obtained from the Hepatocyte and Liver Stem cell
Tissue Bank of Cliniques St Luc, acting under the agreement of the
Belgian Ministry of Health.
2.2. Cell culture and differentiationCultures of human BM-MSCs were established as previously
described (Najar et al., 2013) from 4 different healthy donors (aged
2–22 years old). BM-MSCs were expanded in Dulbecco’s Modi-
fied Eagle Medium low glucose (DMEM-LG) supplemented by 1%
1 f Bioch
p
U
c
w
c
g
M
i
2
2
H
L
(
h
(
f
s
p
c
s
e
d
g
T
1
d
c
2
h
s
1
w
t
l
2
a
d
s
P
O
d
m
D
w
w
T
(
s
c
c
(
i
i
n
p
4
1
a76 A. Wanet et al. / The International Journal o
enicillin streptomycin mixture (Life Technologies, Carlsbad, CA,
SA) and 10% fetal bovine serum (FBS, PAA/GE Healthcare, Pis-
ataway, NJ, USA). Prior to the hepatogenic induction, BM-MSCs
ere seeded on type-1 collagen (BD Biosciences, San Jose, CA)
oated dishes and expanded till 95% confluency (« day 0 »). Hepato-
enic induction was carried out by incubating BM-MSCs in Iscove’s
odified Dulbecco’s Medium (IMDM, Life Technologies) contain-
ng 1% penicillin streptomycin mixture and supplemented with
0 ng/ml EGF (PeproTech, Rocky Hill, NJ, USA) and 10 ng/ml FGF-
 (PeproTech) for 48 h and then with 10 ng/ml FGF-2, 20 ng/ml
GF (PeproTech), 0,61 mg/ml  nicotinamide (Sigma–Aldrich, Saint-
ouis, MO,  USA) and insulin-transferrin-selenium (ITS) mixture 1X
Life Technologies) for 10 days. Cells were then treated with a
epatogenic maturation cocktail containing 20 ng/ml oncostatin M
OSM) (PeproTech), 1 M dexamethasone (Sigma–Aldrich) and ITS
or 10 days. Undifferentiated BM-MSCs were maintained in IMDM
upplemented with 1% FBS. All experiments were performed at
assage 5–6.
Primary human hepatocytes were isolated from 3 healthy
adaveric donors (4 days, 27 and 48 years old) using a clas-
ic two-step perfusion technique as previously described (Najimi
t al., 2007). Hepatocytes were seeded on type-1 collagen coated
ishes and maintained in Williams’E medium (Life Technolo-
ies) supplemented with 1% penicillin-streptomycin, 10% FBS (Life
echnologies), 1.275 M dexamethasone (Aacidexam) and 1.66
0−5 U/ml insulin (Lilly Benelux SA, Brussels, Belgium) for an 8-day
edifferentiation period.
All cells were maintained at 37 ◦C in a humidified atmosphere
ontaining 5% CO2.
.3. Periodic acid Schiff staining
Cells were seeded on coverslips, fixed with 4% paraformalde-
yde for 20 min  and then stained using the periodic acid-schiff
taining system (Sigma–Aldrich). Briefly, cells were incubated with
% periodic acid for 10 min, rinsed several times with deionized
ater, incubated with Schiff’s reagent for 15 min, rinsed several
imes with tap water and then observed under a contrast-phase
ight microscope.
.4. Nucleoids and mitochondrial network visualization and
nalysis
To analyze the mitochondrial network morphology, expanded,
ifferentiated and undifferentiated BM-MSCs seeded on cover-
lips were stained with 100 nM Mitotracker® Green FM (Molecular
robes, Life Technologies) for 30 min  at 37 ◦C and with CellMaskTM
range (Molecular Probes, Life Technologies) at a dilution 1:4000
uring the last 5 min. Live cells were observed using confocal
icroscopy (TCS SP5 II, Leica Microsystems, Wetzlar, Germany).
edifferentiating hepatocytes seeded on coverslips were fixed
ith 4% paraformaldehyde for 20 min, permeabilized for 5 min
ith PBS-1% Triton X-100, and then incubated for 2 h with anti-
OM20 antibody (BD Bioscience #612278) diluted in PBS -1% BSA
1:100). Cells were then incubated for 1 h with an Alexa-labeled
econdary antibody (Molecular Probes) (1:1000) and observed by
onfocal microscopy. The length and branching status of the mito-
hondrial network was determined by calculating the aspect ratio
AR) and end points/branch points ratio of mitochondrial particles
n the entire cell sections using the Image J software accord-
ng to De Vos and Sheetz (De Vos and Sheetz, 2007). To analyze
ucleoids as well as the percentage of the cytoplasmic area occu-
ied by mitochondria, cells were seeded on coverslips, fixed with
% paraformaldehyde for 20 min, permeabilized for 5 min  with PBS-
% Triton X-100, and then incubated for 2 h with an anti-TOM20
ntibody (SC-11415, 1:200) (for mitochondria staining) and anemistry & Cell Biology 54 (2014) 174–185
anti-DNA antibody (Progen AC-30-10, 1:10) (for nucleoid staining)
or an anti--catenin antibody (BD610153, 1:100) (for cytoplasm
staining) diluted in PBS -1% BSA. Cells were then incubated for
1 h with Alexa-labeled secondary antibodies (Molecular Probes)
(1:1000) and observed by confocal microscopy. The number of
nucleoids per cell section, as well as the area occupied by mito-
chondrial and nucleoid or cytoplasmic stainings were calculated
using the ImageJ software.
2.5. Determination of the relative abundance of mtDNA
Total DNA was  isolated using the Wizard Genomic DNA purifi-
cation system (Promega, Fitchburg, MI,  USA). The relative mtDNA
copy number was estimated by quantitative real-time PCR (qPCR)
using primers for the mitochondrial gene NADH dehydrogenase
subunit 2 (ND2) and normalized to the genomic DNA by using
primers for the beclin gene (Table A1). Reactions were performed
using SYBR Green PCR Master mix (Roche) and an ABI 7900 HT
Fast Real Time PCR System (Applied Biosystems, Life Technologies).
Results are expressed relative to expanding BM-MSCs.
2.6. Real-time RT-qPCR analysis
Total RNA was  isolated using the RNeasy Mini kit and Qiacube
(Qiagen, Venlo, The Netherlands) and reverse-transcribed using the
cDNA first strand synthesis kit (Roche Applied Science, Pensberg,
Germany). RT-qPCR was  performed using SYBR Green PCR Mas-
ter mix  (Roche), the primers listed in Table A1 and an ABI 7900
HT Fast Real Time PCR System. The mRNA abundance of glucose-
6-phosphatase catalytic subunit (G6PC), phosphoenolpyruvate
carboxykinase 1 (PEPCK1), ornithine transcarbamylase (OTC) and
tyrosine aminotransferase (TAT) was determined using a PCR array
from Qiagen according to the manufacturer’s instructions. All
results were normalized to the mRNA abundance of the peptidyl-
prolyl cis-trans isomerase E (PPIE), and are expressed relative to
expanding BM-MSCs or hepatocytes at « 0 h ».
2.7. Western blot analysis
Total cell protein lysates were obtained using a buffer con-
taining 7 M urea, 2 M thiourea, 1% CHAPS, 1% ASB14, 1% SDS,
30 mM Tris, pH 8.5 supplemented with Complete Protease Inhibitor
Cocktail (Roche) and 4% phosphatase inhibitor cocktail (25 mM
Na3VO4, 250 mM 4-nitrophenylphosphate, 250 mM glycerophos-
phate, 125 mM NaF). An amount of 25 g of proteins was  resolved
on 12% (PPAR)  or 4–15% (other proteins) Mini-PROTEAN TGX  pre-
cast gels (Biorad, Hercules, CA, USA). Western blotting analysis was
performed using the primary antibodies listed in Table A2, sec-
ondary antibodies coupled to Infrared dyes [(1:5000 (anti-goat IgG)
or 1:10 000 (anti-mouse or anti-rabbit IgG), Li-Cor Biosciences, Lin-
coln, NE, USA)] and detection by infrared fluorescence (Odyssey
scanner, Li-Cor Biosciences). The fluorescence signal intensity of
the detected bands was  calculated using the Odyssey V3.0 applica-
tion software, normalized to the one of Histone 3 (used as loading
control). Results are expressed relative to expanding BM-MSCs or
to dedifferentiating hepatocytes at 18 h.
2.8. Respiration assays
The extracellular flux analyzer XF96 (Seahorse Biosience, North
Billerica, MA,  USA) was  used to measure the oxygen consumption
rate (OCR) and extracellular acidification rate (ECAR) at the end of
the hepatogenic induction step (day 12). The necessity to perform
the analysis on the same day excluded the possibility to analyze the
respiration of corresponding expanding BM-MSCs. The day prior to
the assay, cells were seeded at a density of 20,000 cells/well. A XF
A. Wanet et al. / The International Journal of Biochemistry & Cell Biology 54 (2014) 174–185 177
Table  A1
Sequences of primers used in qPCR.
Genes Forward primer (5′ → 3′) Reverse primer (5′ → 3′)
Albumin TGTTGCATGAGAAAACGCCA GTCGCCTGTTCACCAAGGAT
ATP5A1 (ATP synthase  subunit 1) TCGGTTCTGACCTCGATGCT ACCCGCATAGATAACAGCCAC
Beclin  (nuclear gene) CCCTCATCACAGGGCTCTCTCCA GGGACTGTAGGCTGGGAACTATGC
COX1  (cytochrome c oxidase, subunit 1) CCTGACTGGCATTGTATTAGC TTTTGGCGTAGGTTTGGTCT
COX2  (cytochrome c oxidase, subunit 2) AGATGCAATTCCCGGACGT CATGAAACTGTGGTTTGCTCC
COX4i1 (cytochrome c oxidase, subunit 4 isoform 1) ACCGCGCTCGTTATCATGTG CATGTCCAGCATCCTCTTGGT
mtHSP70 (mitochondrial heat shock protein 70) CTGAAGAAGACCGGCGAAAGA AGCTTGTTGCACTCATCAGCA
ND2  (NADH dehydrogenase, subunit 2 (mitochondrial gene)) TGTTGGTTATACCCTTCCCGTACTA CCTGCAAAGATGGTAGAGTAGATGA
OTC  (ornithine transcarbamoylase) GCGAAATTCGGAATGCACCTT GCTCTGCCAACTTGGTTACAC
PGC-1  (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) TCCTTTCTCTCGCCCAACACGATCT GCATCCGACAGGACAAACAGTGGA
PGC-1  (peroxisome proliferator-activated receptor gamma, coactivator 1 beta) AGCATTGGCTTGGAGCATCT AGGGCTCGTGTTGGTTTCAA
PPAR  (peroxisome proliferator-activated receptor gamma) GATGACAGCGACTTGGCAAT AGGGCTTGTAGCAGGTTGTC
PPIE  (Peptidyl-prolyl cis-trans isomerase E) CCGCTCTTGACCCTGCATAT TCCAAGCAGACCCTGAGGAA
Slug  ATTCGGACCCACACATTACCT CTGTTGCAGTGAGGGCAAGAA
Sox9  CACACAGCTCACTCGACCTTG TTCTTCGGTTATTTTTAGGATCATCTC
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ATDO2  (tryptophan 2,3-dioxygenase) 
Vimentin 
1AT  (alpha-1 antitrypsin)
ell mito stress test (Seahorse Bioscience) was performed according
o the manufacturer’s instructions and using the following chem-
cal concentrations: 1 M oligomycin, 0.5 M carbonyl cyanide
-(trifluoromethoxy)phenylhydrazone (FCCP), 1 M antimycin A
nd 1 M rotenone. Once OCR and ECAR measurements were
erformed, cells were lysed in 0.5 N NaOH and OCR and ECAR mea-
urements were normalized to the protein content of the well. Basal
espiration was calculated by subtracting the non-mitochondrial
xygen consumption (OCR following the addition of both antimycin
 and rotenone) to the basal OCR. ATP coupling efficiency is calcu-
ated by subtracting the non-mitochondrial oxygen consumption
rom the OCR following oligomycin addition and is expressed as
 percentage of the basal respiration. Spare respiratory capacity is
alculated by subtracting the non-mitochondrial oxygen consump-
ion from the OCR following FCCP addition and is expressed as a
ercentage of the basal respiration. For each condition and each
onor, 4–12 technical replicates were performed.
.9. Statistical analyses
Depending on the data to compare, one-tailed T-test (Suppl. Fig.
(A)), one way analysis of variance (Fig. 7(B)) or one way  (Fig. 1(B),
ig. 2(B), Fig. 4(B), Fig. 6, Fig. 7(C))/two ways (Fig. 3 (A)–(C), Fig. 4(A),
ig. 5(A), Fig. 5(B), Suppl. Fig. 2, Suppl. Fig. 3) repeated measure
NOVA tests were performed, assuming data normal distribution.
hen equal variance test failed, Friedman repeated measures anal-
sis of variance on ranks was performed instead (Fig. 4(A) for COX4
rotein abundance). To identify the significantly different groups,
airwise multiple comparisons using the Student-Newman-Keuls
ethod were performed (* or #, p < 0.05; ** or ##, p < 0.01; *** or
##, p < 0.001) (*, comparisons between different time points; #,
omparisons between Diff and Undiff at a particular time point).
ll statistical analyses were done using the SigmaStat 3.2 software
Systat, San Jose, CA, USA).
able A2
ntibodies used for Western-blotting applications.
Target Manufacturer
Histone 3 Cell Signaling
COX1 (Cytochrome c oxidase, subunit 1) Abcam (Camb
COX2 (Cytochrome c oxidase, subunit 2) Abcam (Camb
COX4 (Cytochrome c oxidase, subunit 3) Life Technolog
ATP  synthase  Life Technolog
mtHSP70 (mitochondrial heat shock protein 70) Enzo Life Scie
PPAR  (peroxisome proliferator-activated receptor gamma) Santa Cruz Bio
PGC-1  (peroxisome proliferator-activated receptor gamma,
coactivator 1 alpha)
Santa Cruz BioGAGGAACAGGTGGCTGAATTT GCTCCCTGAAGTGCTCTGTA
GAGGCTGCCAACCGGAACAATG TCCATTTCACGCATCTGGCGTTC
GGGTCAACTGGGCATCACTAA CCCTTTCTCGTCGATGGTCA
3. Results
3.1. The in vitro hepatogenic differentiation of BM-MSCs
BM-MSCs were submitted to a hepatogenic differentiation pro-
tocol that consists of a sequential incubation with growth factors,
cytokines and cofactors (Fig. 1 (A)). The cells obtained during or
at the end of this process, defined as differentiated cells (Diff),
were compared with undifferentiated cells (Undiff) cultured over
the same period in a control medium, as well as with expanding
BM-MSCs (Exp) from the corresponding passage. These two  con-
trol conditions were analyzed to observe the changes due to cell
differentiation per se or to the prolonged in vitro culture period.
The efficiency of hepatogenic differentiation of BM-MSCs was
evaluated at the morphologic, genetic and functional levels. At the
end of the last maturation step, an increased mRNA abundance of
several hepatic markers such as albumin, -1-antitrypsin (1AT) or
tryptophan 2,3-dioxygenase (TDO2) (p = 0.053) was  noticed. At the
same time, the abundance of the pluripotent marker Sox9 mRNA
was suppressed (Fig. 1 (B)).
While relatively heterogeneous, differentiated cells also develop
an increased ability to store glycogen as evidenced by periodic
acid–Schiff (PAS) staining (Fig. 1 (C)). On these micrographs, one
can observe the acquisition of the typical hepatocyte-like polygonal
shape of the differentiated cells.
3.2. The mitochondrial network of BM-MSCs undergoes
morphological changes during hepatogenic differentiation
Although the globular shape and perinuclear localization of
mitochondria in ESCs and iPSCs has been regarded as a poten-
tial marker of pluripotency (Lonergan, Bavister, 2007), it is not
clearly established if the morphology of the mitochondrial net-
work is pluripotency-dependent or stem cell specific. Staining of
 Reference Dilution factor
 Technology (Danvers, MA,  USA) #4499 1:5000
ridge, UK) ab14705 1:2000
ridge, UK) ab110258 1:2000
ies (Carlsbad, CA, USA) A21348 1:500
ies (Carlsbad, CA, USA) A21350 1:1000
nces (Farmingdale, NY, USA) ALX-804-077 1:1000
technology (Dallas, TX, USA) SC-7196 1:500
technology (Dallas, TX, USA) SC-13067 1:500
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Fig. 1. The hepatogenic differentiation of BM-MSCs results in the acquisition of hepatic features. (A): Representation of the hepatogenic differentiation protocol and exper-
imental conditions. (B): mRNA abundance of several pluripotency (Sox9) and hepatic markers (Albumin, -1-antitrypsin (1AT), tryptophan 2,3-dioxygenase (TDO2)) in
expanding, differentiated and undifferentiated BM-MSCs determined using RT-qPCR. Data are presented as mean ± SEM (n = 4 independent donor cells). (C): Periodic-acid
Schiff staining illustrating the ability of some differentiated cells to store glycogen.
Fig. 2. The hepatogenic differentiation of BM-MSCs is accompanied by changes in the mitochondrial network morphology. (A): Living expanding, differentiated and undif-
ferentiated BM-MSCs were stained with mitotracker green® FM (green) and cell MaskTM Orange (red) and observed using confocal microscopy. (B): Two parameters of the
mitochondrial network morphology, the aspect ratio and end points/branch points ratio were analyzed for 10 cells for each condition and for 4 different donors. Data were
first  averaged for the 10 cells obtained for each donor in each condition and are presented as mean ± SEM of the data obtained for the 4 independent donors.
A. Wanet et al. / The International Journal of Biochemistry & Cell Biology 54 (2014) 174–185 179
Fig. 3. An increase in mitochondria and mtDNA abundance is observed during the hepatogenic differentiation of BM-MSCs. (A): The percentage of the cytoplasmic area
(visualized by -catenin immunostaining, see Fig. 3 (D)) occupied by mitochondria (visualized by TOM20 immunostaining, see Fig. 3 (D)) was  determined for 10 cells per
donor  for each condition and for 4 different donors. Data were first averaged for the 10 cells obtained for each donor in each condition and are presented as mean ± SEM of
the  data obtained for the 4 independent donors. (B): Relative abundance of the mtDNA content determined by quantitative PCR. Data are presented as mean ± SEM (n = 4
independent donor cells). (C): The number of nucleoids per cell section (determined by nucleoid immunostaining, see Fig. 3 (E)) was calculated for 10 cells per donor for each
condition and for 4 different donors. Data were first averaged for the 10 cells obtained for each donor in each condition and are presented as mean ± SEM of the data obtained
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Sor  the 4 independent donors. (D): Immunofluorescence staining of mitochondria (u
n  red) visualized by confocal microscopy. (E): Immunofluorescence staining of nu
ntibody, in red) visualized by confocal microscopy.
he mitochondrial network of BM-MSCs with MitoTracker® Green
a probe that stains mitochondria regardless of membrane poten-
ial) (Zhang, 1994) and CellMaskTM Orange (for staining the plasma
embrane) revealed that expanding BM-MSCs display a developed
etwork composed of thread-like mitochondria spread throughout
he cytoplasm (Fig. 2 (A)). Undifferentiated cells also display a mito-
hondrial population organized in a branched/reticulated network,
et we found a more fragmented morphology, mostly composed of
od-like particles, in differentiated cells. Quantitative analysis of
itochondrial morphology with the ImageJ software (De Vos and
heetz, 2007) demonstrated, in differentiated cells, a decrease inn anti-TOM20 antibody, in green) and cytoplasm (using an anti--catenin antibody,
s (using an anti-DNA antibody, in green) and mitochondria (using an anti-TOM20
the aspect ratio, which measures the elongation of mitochondrial
particles, and an increased ratio of end points to branch points,
which is inversely proportional to the mitochondrial networking
(Fig. 2 (B)).
3.3. Hepatogenic differentiation of BM-MSCs is accompanied by a
mitochondrial biogenesis resulting in enhanced mitochondrial
respiration
BM-MSCs appear to display a more elongated and more devel-
oped mitochondrial network than the one reported in ESCs.
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Fig. 4. An increase in several mitochondrial protein abundance and respiration is observed during the hepatogenic differentiation of BM-MSCs. (A): Relative abundance
of  several mitochondrial proteins was analyzed by Western-Blot. Signal intensity was quantified and normalized to the abundance of histone 3 (loading control). Data are
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alculate the basal respiration, respiration coupling efficiency and spare respirator
ssessed. Data are presented as mean ± SEM (n = 4 independent donor cells).
evertheless, we hypothesized that both quantitative and quali-
ative changes in mitochondrial composition, perhaps driven by
itochondrial biogenesis regulators and leading to a metabolic
hift toward increased OXPHOS, may  accompany the hepatogenic
ifferentiation of BM-MSCs. We  thus first analyzed on immuno-
uorescence sections observed by confocal microscopy the fraction
f cytoplasmic area occupied by mitochondria (Fig. 3 (A) and
D)). Interestingly, we evidenced a significant increase in the per-
entage of the cytoplasmic area occupied by mitochondria, rising
rom 11.23 ± 0.71% in expanding BM-MSCs, to 15.93 ± 1.25% and
6.32 ± 0.96% at the end of the hepatic induction and maturation
teps respectively, while slightly decreasing in undifferentiated
ells. We  next analyzed the evolution of mtDNA copy number
uring the cell differentiation process. We  observed a significant
nduction of mtDNA copy number in differentiating cells when
ompared with expanding BM-MSCs, reaching 2.13 ± 0.14 folds
t the end of the induction step (day 12) and 3.87 ± 0.25 folds at
he end of the maturation step (day 22). The mtDNA copy num-
er remained stable in undifferentiated cells (Fig. 3 (B)). Although
o change was found at the end of the hepatic induction step, we
videnced an increase in the relative number of nucleoids per cell
t the end of the hepatic maturation step in differentiated cellsto oligomycin, FCCP and antimycin A in combination with rotenone were used to
city of differentiated and undifferentiated cells at day 12. The basal ECAR was also
(Fig. 3 (C) and (E)). Nevertheless, no significant difference was
evidenced when considering the area density of nucleoids relative
to mitochondria, which could be explained by a decreased size of
nucleoids in differentiating cells when compared to expanding cells
(Suppl. Fig. 2 (A) and (B)).
Given that mitochondrial biogenesis also requires the synthe-
sis and import of many mitochondrial proteins, we next analyzed
the abundance of several mitochondrial proteins throughout the
differentiation process. The abundance of mtHSP70, a mitochon-
drial matrix chaperone required for the import and folding of
most mitochondrial inner membrane and matrix proteins (Deocaris
et al., 2006), although not significantly modified at the mRNA level
(Suppl. Fig. 3) was found to be significantly induced at the protein
level in differentiating cells (Fig. 4 (A)). In addition, the abundance
of several proteins involved in the OXPHOS chain increased dur-
ing the hepatogenic differentiation of BM-MSCs, both at the mRNA
(Suppl. Fig. 3) and protein levels (Fig. 4 (A) and Suppl. Fig. 4). The
protein abundance of the subunit II of the cytochrome c oxidase
(COX2), which is encoded by mtDNA, was  found to be significantly
increased in differentiated cells (vs. expanding or undifferentiated
BM-MSCs), with a maximum abundance reached at the end of the
hepatogenic induction step (day 12). A comparable induction of
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Fig. 5. An increased expression of several mitochondrial biogenesis regulators is observed during the hepatogenic differentiation of BM-MSCs. (A) PGC-1,  PGC-1 and
PPAR  mRNA abundance was  assessed by RT-qPCR. Data are presented as mean ± SEM (n = 4 independent donor cells). (B): Relative protein abundance was  analyzed by
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ells).
he subunit IV (COX4, encoded by nDNA) occurred during the hep-
togenic induction step, while the abundance of the subunit  of
he ATP synthase increased continuously during the hepatogenic
nduction and maturation steps. While an increased abundance
f the subunit I of the cytochrome c oxidase (COX1) (encoded by
tDNA) was also found in differentiating cells, the difference was
ot significant in our experimental conditions.
The increased abundance of several OXPHOS complex subunits
rompted us to analyze the mitochondrial respiration at the end of
he hepatogenic induction step. The OCR was thus measured in a
asal condition after the addition of oligomycin A (an ATP synthase
nhibitor, in order to evaluate the coupling efficiency of the respi-
atory chain), FCCP (an uncoupling protonophore, to evaluate the
pare respiratory capacity of cells), and a combination of antimycin
 and rotenone (mitochondrial complex III and I inhibitors, respec-
ively). These conditions were necessary in order to calculate and
ubtract the non-mitochondrial oxygen consumption from other
easurements (Brand and Nicholls, 2011) (Fig. 4 (B)). We  found
hat the basal respiration was significantly increased in differenti-
ted vs. undifferentiated cells, which suggests that differentiated
ells rely more on OXPHOS for their ATP production. Moreover,
he coupling efficiency, representing the fraction of the basal res-
iration that is used for ATP production, was significantly higher
n differentiated cells. The spare respiratory capacity, which repre-
ents the cell’s ability to increase substrates and electron flux across
he OXPHOS chain to respond to an increased energy demand, was
lso higher in differentiated cells. Together, these data demonstrate
hat, in a basal condition, differentiated cells have a more efficient
XPHOS system and rely more on OXPHOS. Also, differentiated cells
an increase their reliance on OXPHOS during increased energy
emand. In addition to measuring the OCR, we  also analyzed the
CAR in a basal condition. We  observed a slightly lower ECAR in
ifferentiated vs. undifferentiated cells, but the difference was not
tatistically significant. Altogether, these data strongly support a
etabolic shift toward increased OXPHOS during the hepatogenic
nduction of BM-MSCs.e 3 (loading control). Data are presented as mean ± SEM (n = 4 independent donor
3.4. Several mitochondrial biogenesis regulators are increased
during the hepatogenic differentiation of BM-MSCs
In order to investigate the potential mechanisms regulating the
mitochondrial biogenesis in differentiating BM-MSCs, we analyzed
the relative mRNA abundance of most of the well-known regulators
of mitochondrial biogenesis. These regulators included PGC-1,
PGC-1,  PPAR, - and -, Nrf1 and Nrf2, ERR, POLG, POLG2,
PolRmt, and TFAM at different time points of the differentiation
process. Although no change was observed in the expression of
most of these candidates (data not shown), we  evidenced a trend
toward an induction of the mRNA abundance of PPAR (with no
isoform discrimination) and of the global co-regulators PGC-1 and
PGC-1 (Fig. 5 (A)). At the protein level, we  observed a significant
induction of PPAR1 at the end of the differentiation, and of both
PPAR2 and PGC-1 at the end of the induction and maturation
steps (Fig. 5 (B)). Together with the previous results, these data fur-
ther support that an enhanced mitochondrial biogenesis process
occurs during the hepatogenic differentiation of BM-MSCs. This
process involves at least two well-known regulators of mitochon-
drial biogenesis and results in the replication of mtDNA, synthesis
of mitochondrial proteins and increased mitochondrial respiration.
3.5. Mitochondrial modifications occur during the in vitro
dedifferentiation of human primary hepatocytes
The reprogramming of somatic cells into iPSCs correlates with a
reduction of mitochondrial abundance and function, a remodeling
of which is required for the induction of pluripotency in iPSCs (Xu
et al., 2013). We  thus aimed to determine if similar structural or
functional remodeling of mitochondria occurs during the sponta-
neous in vitro dedifferentiation of hepatocytes, in order to evidence
reverse mitochondrial changes correlating with hepatocyte (de-
)differentiation.
A drastic loss of multiple hepatic gene markers, includ-
ing albumin (p = 0.055), glucose-6-phosphatase (G6PC) (p = 0.054),
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cig. 6. Primary human hepatocyte dedifferentiation is associated with the rapid loss 
arkers (vimentin, snail). mRNA abundance was  assessed by RT-qPCR. Data are pre
hosphoenolpyruvate carboxykinase 1 (PEPCK1), ornithine tran-
carbamylase (OTC) and tyrosine amino-transferase (TAT) was
oted within 18 h post-isolation at the mRNA level (Fig. 6).
egarding mesenchymal markers (which are induced during the
pontaneous in vitro dedifferentiation of hepatocytes (Meyer,
zieran, 2013), a statistically significant induction of vimentin,
long with a moderate increase in the abundance of slug, were
bserved at the mRNA level (Fig. 6).
Interestingly, the analysis of the mitochondrial morphology
hroughout the dedifferentiation process exhibited changes to the
etwork structure that were the opposite of those observed in
he differentiation model (Fig. 7 (A)). Indeed, the mitochondrial
spect ratio increased, while the ratio of end points to branch points
ecreased during the dedifferentiation process (Fig. 7 (B)), which
upports an elongation and increased networking of mitochondria.
n addition, we found a repression of the abundance of several
XPHOS complex subunits heretofore demonstrated to be induced
n the differentiation model: COX1, COX2, COX4, and the subunit 
f the ATP synthase (Fig. 7 (C) and Suppl. Fig. 5). These data suggest
hat opposite changes in the mitochondrial network morphology,
nd in the abundance of proteins involved in mitochondrial activity,
ccur during the differentiation of BM-MSCs into hepatocyte-like
ells and in the dedifferentiation of primary hepatocytes.
. Discussion
Recent discoveries have demonstrated a strong interplay
etween mitochondrial biogenesis/function and stem-
ess/differentiation programs in ESCs and iPSCs. However,
vidence of a similar phenomenon in MSCs is (to our knowledge)
ery scarce, and limited to the contexts of osteogenic (Chen, Shih,
008, Palomaki, Pietila, 2013, Pietila et al., 2010, Pietila, Palomaki,
012) and adipogenic (Hofmann et al., 2012, Huang, Chen, 2011,
ormos, Anso, 2011) differentiation. It is still unclear whether
his phenomenon is a hallmark of cell differentiation programs,
r displays specificities depending on the stem cell types or lin-
ages into which they are differentiated. Investigation of multiple
odels is therefore required. In this study we provide, for the first
ime, a detailed characterization of the mitochondrial changes
ccurring during the hepatogenic differentiation of BM-MSCs.
e first evidenced an increased mitochondria to cytoplasm ratio,
uggesting that the cytoplasm of differentiating cells is enriched
n mitochondria compared to expanding or undifferentiating
ells. The induction of mtDNA abundance during the hepatogenicatic (albumin, G6PC, PEPCK1, OTC, TAT) and progressive acquisition of mesenchymal
d as mean ± SEM (n = 3 independent donor cells).
differentiation (3.87 folds) appeared stronger than during the
osteogenic differentiation of BM-MSCs (1.37 folds) (Chen, Shih,
2008) and resulted at the end of the hepatic maturation step
in an increased number of nucleoids. Nevertheless, we  did not
find any significant change in the area density of nucleoids when
normalized to the mitochondrial content (Suppl. Fig. 2(A)), which
can be explained both by an increase in mitochondrial content
as well as by a decrease in nucleoid size (Suppl. Fig. 2(B)). This
decrease in nucleoid size both in differentiated and undifferenti-
ated cells versus expanding cells might be explained by the serum
withdrawal in those conditions, as the serum deprivation has
been associated with more condensed nucleoids (Prachar, 2010).
Obviously this nucleoid compaction does not impact mtDNA-
encoded gene expression, as both COX1 and COX2 are similarly
expressed in expanding and undifferentiated BM-MSCs (Suppl.
Fig. 3).
In addition to the increase in mtDNA, we observed (as already
demonstrated during the osteogenic (Chen, Shih, 2008) and adi-
pogenic (Hofmann, Beyer, 2012) differentiation of BM-MSCs) an
increased expression for several mitochondrial proteins, includ-
ing OXPHOS subunits. Although the mitochondrial chaperone
mtHSP70 is upregulated at the post-transcriptional level only, we
evidenced an increased mRNA abundance for COX1, COX2, COX4i1
and ATP5A1. Interestingly, the mRNA levels of nDNA-encoded sub-
units (COX4i1 and ATP5A1) were induced to a lesser extent than
the protein levels, while similar mRNA and protein induction folds
were found for mtDNA-encoded subunits. These data suggest that
nDNA-encoded and mtDNA-encoded subunit expression is upre-
gulated by different mechanisms to finally reach an increased and
balanced production of OXPHOS complexes.
Although we  found a continuous increase in the mtDNA abun-
dance and a still significantly increased abundance in several
mitochondrial proteins and biogenesis regulators at the end of
the hepatogenic maturation step (day 22), we did notice a peak
in the abundance of several mitochondrial proteins at the end of
the induction step (day 12). These data suggest that the mtDNA
copy number is not necessarily associated with OXPHOS subunit
expression, which is in agreement with data showing that mtDNA
is not correlated with the cytochrome c oxidase activity in different
cell types (Van den Bogert et al., 1993). The different constituent
of mitochondria (lipids, mtDNA and proteins) might therefore
be differentially regulated. Interestingly, studies of adipogenic or
osteogenic differentiation of BM-MSCs also evidenced an increase
in mitochondrial biogenesis and function during the early steps
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Fig. 7. Opposite changes in the mitochondrial network morphology and OXPHOS protein abundance are observed in dedifferentiating primary hepatocytes. (A) The mito-
chondrial network morphology was visualized by performing a TOM20 immunofluorescence combined with confocal microscopy visualization. (B): The aspect ratio and
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dnd  points/branch points ratio were analyzed for 12 cells for each time-point of the
bundance of several mitochondrial proteins was  analyzed by Western-Blot. Signal 
ata  are presented as mean ± SEM (n = 3 independent donor cells) and expressed re
f the differentiation process (Chen, Shih, 2008, Pietila, Palomaki,
012, Tormos, Anso, 2011). It remains to be determined whether
his increased mitochondrial abundance and activity, which pre-
edes the hepatogenic maturation in our model, is important for
he commitment and early induction of differentiation, and/or if
he continuous increase in mtDNA and mitochondrial abundance
re also required for the late differentiation stages.
At the functional level, we demonstrated an increased oxida-
ive activity (basal respiration), capacity (respiratory reserve), and
fficiency (coupling efficiency) of differentiating cells. Therefore,
oth quantitative and qualitative modifications of the mitochon-
rial network occurred during the hepatogenic differentiation of
M-MSCs, resulting in enhanced mitochondrial respiration. We
ext evidenced an increased expression of the co-activator PGC-1
Fig. 5), considered a key regulator of mitochondrial biogenesis and
xidative metabolism (Scarpulla, 2011). We  also found an induction
f PPAR both during the steps of hepatogenic induction (isoform 2)
nd maturation (both isoforms). Interestingly, these data are con-
istent with the previously described PPAR-dependent induction
f PGC-1 and - expression (Deng et al., 2011, Hondares et al.,
006). These co-regulators may  in turn drive the mitochondrial bio-
enesis process and oxidative switch by co-activating the many TFs
hat regulate mitochondrial gene expression.
The interest devoted to mitochondrial abundance and activity in
temness and differentiation results from the relevance conferred
y observations made in multiple models (diverse stem cells and
ifferentiation types (Chen, Hsu, 2012, Xu et al., 2013)). Yet there
s also the intriguing fact that opposite modifications occur dur-
ng the reprogramming of somatic cells into iPSCs (Xu et al., 2013).
his process has been, so far, only demonstrated in the artificial
ontext of genetically-engineered reprogramming. In this study, we
ook advantage of the spontaneous dedifferentiation process occur-
ing during primary hepatocytes in vitro culture to test whether
pposite changes are observed during hepatic differentiation and
edifferentiation.erentiation process. Data are presented as mean ± standard deviation. (C). Relative
ity was  quantified and normalized to the abundance of histone 3 (loading control).
 to the 18 h time point.
Interestingly, we  evidenced a decreased abundance in several
OXPHOS protein subunits (Fig. 7 (C)), all of which were induced in
the BM-MSCs hepatogenic differentiation model (Fig. 4 (A)). Impor-
tantly, the spontaneous dedifferentiation process of hepatocytes
does not lead to the re-establishment of pluripotency like in iPSC
reprogramming. Our data therefore suggest that the diminished
mitochondrial OXPHOS subunit abundance is observed as soon as
cells are loosing their fully differentiated phenotype, and do not
require the re-acquisition of pluripotency. Although this would
require validation in other models, these data might suggest that
mitochondria are remodeled throughout the kinetics of differentia-
tion/dedifferentiation programs and not involved in a time-limited
switch between pluripotency and commitment to a differentiation
program.
BM-MSCs display tubular interconnected mitochondria spread
throughout the cytoplasm. While ESCs are generally reported to
display granular mitochondria (although some discrepancies exist,
depending on the studies) (Lonergan et al., 2006, Mandal, Lindgren,
2011, Sathananthan et al., 2002, St John, Ramalho-Santos, 2005),
we observed in human umbilical cord-derived MSCs, as well as
in adult human liver mesenchymal stem/progenitor cells, a more
comparable mitochondrial morphology than in BM-MSCs (unpub-
lished data). This developed tubular mitochondrial network may
thus be typical of mesenchymal stem/progenitor cells. During hep-
atogenic differentiation, the mitochondrial network of BM-MSCs
undergoes a fragmentation, leading to smaller mitochondria. The
reasons for these modifications in the mitochondrial network
morphology during hepatogenic differentiation are still unknown.
However, several hypotheses may  partly explain these changes.
First, an increasing number of studies point toward an involve-
ment of mitochondrial fusion/fission processes in cell proliferation
and differentiation programs. As recently reviewed by Mitra (Mitra,
2013), multiple evidence supports the hypothesis that a reduced
expression or activity of dynamin-related protein 1 (Drp1, involved
in the mitochondrial fission machinery) results in unopposed
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itochondrial fusion and promotes cell proliferation through the
uild-up of cyclin E, which regulates the entry in the S-phase of
he cell cycle. The highly fused mitochondrial network of expand-
ng BM-MSCs (Fig. 2) may  therefore partly reflect the proliferation
tatus of these cells. In addition, we observed the progressive
cquisition of a slightly more fused mitochondrial network dur-
ng the dedifferentiation of hepatocytes (Fig. 7 (A) and (B)). Since
solated hepatocytes re-enter proliferation during isolation and
n vitro culture (Elaut, Henkens, 2006), this hypothesis may  also
artly explain the increased branching and elongation of mitochon-
ria during early dedifferentiation. Secondly, it has been suggested
hat mitochondrial dynamics influence OXPHOS capacity (Benard
t al., 2010). For instance, it has been demonstrated that inhibiting
itochondrial fission, through down-regulating Drp1 expression,
esults in decreased mtDNA abundance and OXPHOS activity
Parone et al., 2008). Conversely, OXPHOS activity is also reported to
nfluence mitochondrial dynamics (Benard, Bellance, 2010). There-
ore, the modifications of the mitochondrial network morphology
f differentiating BM-MSCs may  represent a prerequisite (or a con-
equence) of the observed increased OXPHOS activity. Thirdly, the
pposite modifications in mitochondrial network morphology may
esult from changes in cytoskeleton structure during the hepatic
ifferentiation and dedifferentiation processes. Indeed, we  found
n important decrease in -actin and -tubulin abundance during
he differentiation of BM-MSCs, while a strong induction of these
roteins was observed during the dedifferentiation of hepatocytes
data not shown). Interestingly, mitochondrial location, shape, and
ubular status are known to be regulated through their interaction
ith, and modification of, shape proteins and cytoskeleton ele-
ents (such as the microtubules, microfilaments, and intermediary
lament families), resulting in changes in mitochondrial morphol-
gy (Kuznetsov et al., 2009).
. Conclusion
While we observed a fragmentation of the mitochondrial net-
ork morphology and an induction of mitochondrial biogenesis
nd activity during the hepatogenic differentiation of BM-MSCs,
e reported several opposite changes during the spontaneous ded-
fferentiation of primary hepatocytes. These observations support
he hypothesis of a strong involvement of mitochondria and mito-
hondrial metabolism in regulating the differentiation of stem cells
nd dedifferentiation or reprogramming events. Further research is
till required to unravel the mechanisms involved in the interplay
etween these two processes. Understanding how these processes
re regulated, and determining if they regulate each other, is of
reat interest for the improvement of directed differentiation of
tem cells into specific cell types. Even though there is continuous
mprovement of their efficiency, current differentiation protocols
o not enable one to reach a terminal differentiation status as
bserved in primary somatic cells. This is particularly true in the
ontext of hepatic differentiation, in which even the most effi-
ient protocols do not allow for reaching similar levels of hepatic
unctions, or inducing all hepatic activities simultaneously (Zhang
t al., 2013, Zhou et al., 2012). On the other hand, understanding
ow opposite mitochondrial modifications occur during primary
epatocyte dedifferentiation may, in turn, help to preserve them
n a more differentiated status. Understanding the role played by
itochondria in hepatic differentiation and dedifferentiation may
herefore be useful in regenerative medicine and pharmacological
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